News

Incanthera plc (AQSE:INC), the company specially focussed on innovative technologies in dermatology and oncology, announces that it will be presenting at Proactive’s One2One Investor Forum in London at 6pm today (16 May 2024) to an audience of high net worth investors, fund managers, private client brokers and analysts.

Incanthera will be delivering a hand-out investor presentation. The presentation, which will not contain any inside information, will be made available shortly on its website, www.incanthera.com.

RNS Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained in this announcement is of a non-regulatory nature.

Download the Presentation

For further information please contact:

Incanthera plc
www.incanthera.com

Tim McCarthy, Chairman
tim.mccarthy@incanthera.com
+44 (0) 7831 675747

Simon Ward, Chief Executive Officer
simon.ward@incanthera.com
+44 (0) 7747 625506

Suzanne Brocks, Head of Communications
suzanne.brocks@incanthera.com
+44 (0) 7776 234600

Broker:
Stanford Capital Partners Ltd
Patrick Claridge / Bob Pountney
+44 (0) 20 3650 3650/51

Notes to Editors

About Incanthera plc

Incanthera is a specialist company focused on innovative technologies in dermatology and oncology. It seeks to identify and develop innovative solutions to current clinical, commercially relevant unmet needs, utilising new technology from leading specialists and academic institutions as well as its in-house development team.

The Company originated from the Institute of Cancer Therapeutics ("ICT") at the University of Bradford. Incanthera's strategy is to develop each candidate in its portfolio from initial acquisition or discovery to securing its future through commercially valuable partnerships at the earliest opportunity in its development pathway.

For more information on the Company please visit: www.incanthera.com

@incantheraplc